Dupilumab in HIV-positive patients: A case series report of 4 patients
- PMID: 33304976
- PMCID: PMC7718127
- DOI: 10.1016/j.jdcr.2020.09.023
Dupilumab in HIV-positive patients: A case series report of 4 patients
Keywords: AD, atopic dermatitis; BSA, body surface area; HAART, highly active antiretroviral therapy; HIV; IGA, investigator global assessment; TH2, helper T cell type 2; atopic dermatitis; biologics; dupilumab.
Figures
Similar articles
-
Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.JAMA Dermatol. 2018 Oct 1;154(10):1208-1211. doi: 10.1001/jamadermatol.2018.2690. JAMA Dermatol. 2018. PMID: 30167653 Free PMC article.
-
Rosacea associated with dupilumab therapy.J Dermatolog Treat. 2021 Feb;32(1):114-116. doi: 10.1080/09546634.2019.1624683. Epub 2019 Jun 9. J Dermatolog Treat. 2021. PMID: 31132923
-
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.Br J Dermatol. 2019 Jul;181(1):80-87. doi: 10.1111/bjd.17791. Epub 2019 Apr 11. Br J Dermatol. 2019. PMID: 30791102 Free PMC article. Clinical Trial.
-
Dupilumab: A review of its use in the treatment of atopic dermatitis.J Am Acad Dermatol. 2018 Mar;78(3 Suppl 1):S28-S36. doi: 10.1016/j.jaad.2017.12.022. J Am Acad Dermatol. 2018. PMID: 29471919 Review.
-
Dupilumab for treatment of atopic dermatitis.Expert Rev Clin Pharmacol. 2018 May;11(5):467-474. doi: 10.1080/17512433.2018.1449642. Epub 2018 Mar 20. Expert Rev Clin Pharmacol. 2018. PMID: 29557246 Review.
Cited by
-
Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.Int J Dermatol. 2021 Apr;60(4):514-515. doi: 10.1111/ijd.15499. Epub 2021 Feb 28. Int J Dermatol. 2021. PMID: 33644864 Free PMC article. No abstract available.
-
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14. Dermatol Reports. 2023. PMID: 38957642 Free PMC article.
References
-
- Mollanazar N., Qiu C., Aldrich J. Use of dupilumab in patients who are HIV-positive: report of four cases. Br J Dermatol. 2019;181(6):1311–1312. - PubMed
-
- Yechiel B. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers - A review and hypothesis. Virus Genes. 2004;28(1):5–18. - PubMed
-
- Rudikoff D. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep. 2002;2(4):275–281. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous